Hiddo J. L. Heerspink, PharmD, PhD, discusses SOLSTICE elecoglipron data, finerenone in FSGS, and glucagon’s kidney effects from ASN Kidney Week 2026.
|Articles|August 12, 2022
Daily OTC Pearl: ZuPOO
Author(s)Saro Arakelians, PharmD
ZuPOO is indicated for gut support, and specifically for colon and gut cleansing.
Advertisement
OTC/Lifestyle Pearl of the Day: ZuPOO
Indication: ZuPOO is a dietary supplement designed for gut support, and specifically for colon and gut cleansing.
Insight:
- ZuPOO is designed to help flush excess waste from the gut and intestines. This allows for a smoother digestion process and healthier gut.
- Directions: Patients should take 2 capsules with a full glass of water. They may notice a buildup of gas over the first 12 to 24 hours, but can expect a flushing of waste within 48 hours. Patients should continue taking zuPOO before bed for 15 days to complete a full flush of the digestive system. The manufacturer notes that they do not recommend taking zuPOO more frequently than at a rate of one full cleanse per 90 days.
- The capsule is made from bovine gelatin, so the product overall is not vegan. However, the contents are vegan-friendly.
- ZuPOO is dairy-free, however, it is processed in the same facility as some dairy-containing products.
- Keep out of reach of children.
Source:
Advertisement
Related to this article
Pharmacy performance measures should recognize clinical interventions, patient counseling, prescriber collaboration, and outcomes—not prescription volume alone.
CMS’s GLP-1 Bridge demo bypasses Part D to cover select obesity drugs, with a $50 monthly copay, PA workflow, and strict eligibility through 2027.
Two Kidney Week 2026 analyses tie SGLT2 inhibitors to kidney, CV, and survival gains in T2D, yet over half of patients with diabetic CKD receive neither.
Two Kidney Week 2026 abstracts show a dose-response link between cardiovascular-kidney-metabolic syndrome (CKM) stage and chronic kidney disease (CKD), while primary care clinicians cite evidence and workflow barriers.
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
The approval offers a once-weekly basal insulin treatment option for patients, reducing the frequency of injections.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Prescription Volume: Measuring the Pharmacist’s Value
2
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
3
SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused
4
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
5